Search by Drug Name or NDC

    NDC 36000-0297-24 CIPROFLOXACIN 2 mg/mL Details

    CIPROFLOXACIN 2 mg/mL

    CIPROFLOXACIN is a INTRAVENOUS INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Baxter Healthcare Corporation. The primary component is CIPROFLOXACIN.

    Product Information

    NDC 36000-0297
    Product ID 36000-297_65c9048d-3b05-4df9-9b61-5ea327e4c7aa
    Associated GPIs 05000020112024
    GCN Sequence Number 015920
    GCN Sequence Number Description ciprofloxacin in 5 % dextrose PIGGYBACK 200MG/0.1L INTRAVEN
    HIC3 W1Q
    HIC3 Description QUINOLONE ANTIBIOTICS
    GCN 52121
    HICL Sequence Number 006071
    HICL Sequence Number Description CIPROFLOXACIN LACTATE/DEXTROSE 5 % IN WATER
    Brand/Generic Generic
    Proprietary Name CIPROFLOXACIN
    Proprietary Name Suffix n/a
    Non-Proprietary Name CIPROFLOXACIN
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form INJECTION, SOLUTION
    Route INTRAVENOUS
    Active Ingredient Strength 2
    Active Ingredient Units mg/mL
    Substance Name CIPROFLOXACIN
    Labeler Name Baxter Healthcare Corporation
    Pharmaceutical Class Cytochrome P450 1A2 Inhibitors [MoA], Fluoroquinolone Antibacterial [EPC], Fluoroquinolones [CS]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA078024
    Listing Certified Through 2024-12-31

    Package

    NDC 36000-0297-24 (36000029724)

    NDC Package Code 36000-297-24
    Billing NDC 36000029724
    Package 100 mL in 1 BAG (36000-297-24)
    Marketing Start Date 2019-12-23
    NDC Exclude Flag N
    Pricing Information N/A